FDA
- Status: approved
Application of crisaborole twice daily (Application of crisaborole twice daily) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.